Homology modeling in drug discovery: current trends and applications

被引：306

作者：

Cavasotto, Claudio N. ^{[1
]}

Phatak, Sharangdhar S. ^{[1
]}

机构：

[1] Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX 77030 USA

来源：

DRUG DISCOVERY TODAY | 2009年 / 14卷 / 13-14期

关键词：

PROTEIN-STRUCTURE PREDICTION; HIGH-THROUGHPUT DOCKING; LIGAND DOCKING; BINDING-SITE; STRUCTURAL GENOMICS; COUPLED RECEPTOR; 3D STRUCTURES; INHIBITORS; DESIGN; IDENTIFICATION;

D O I：

10.1016/j.drudis.2009.04.006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

As structural genomics (SG) projects continue to deposit representative 3D structures of proteins, homology modeling methods will play an increasing role in structure-based drug discovery. Although computational structure prediction methods provide a cost-effective alternative in the absence of experimental structures, developing accurate enough models still remains a big challenge. In this contribution, we report the current developments in this field, discuss in silico modeling limitations, and review the successful application of this technique to different stages of the drug discovery process.

引用

页码：676 / 683

页数：8

共 74 条

[1] The process of structure-based drug design [J].

Anderson, AC .

CHEMISTRY & BIOLOGY, 2003, 10 (09) :787-797

[2]

Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5

[3] Proposed structural models of the prothrombinase (FXa-FVa) complex [J].

Autin, L ;

Steen, M ;

Dahlbäck, B ;

Villoutreix, BO .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 63 (03) :440-450

[4] Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery [J].

Blundell, TL ;

Sibanda, BL ;

Montalvao, RW ;

Brewerton, S ;

Chelliah, V ;

Worth, CL ;

Harmer, NJ ;

Davies, O ;

Burke, D .

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1467) :413-423

[5] Contributions to the NIH-NIGMS Protein Structure Initiative from the PSI production centers [J].

Burley, Stephen K. ;

Joachimiak, Andrzej ;

Montelione, Gaetano T. ;

Wilson, Ian A. .

STRUCTURE, 2008, 16 (01) :5-11

[6] Structure-based active site profiles for genome analysis and functional family subclassification [J].

Cammer, SA ;

Hoffman, BT ;

Speir, JA ;

Canady, MA ;

Nelson, MR ;

Knutson, S ;

Gallina, M ;

Baxter, SM ;

Fetrow, JS .

JOURNAL OF MOLECULAR BIOLOGY, 2003, 334 (03) :387-401

[7] Docking and high throughput docking: Successes and the challenge of protein flexibility [J].

Cavasotto, Claudio N. ;

Singh, Narender .

CURRENT COMPUTER-AIDED DRUG DESIGN, 2008, 4 (03) :221-234

[8] Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening [J].

Cavasotto, Claudio N. ;

Orry, Andrew J. W. ;

Murgolo, Nicholas J. ;

Czarniecki, Michael F. ;

Kocsi, Sue Ann ;

Hawes, Brian E. ;

O'Neill, Kim A. ;

Hine, Heather ;

Burton, Marybeth S. ;

Voigt, Johannes H. ;

Abagyan, Ruben A. ;

Bayne, Marvin L. ;

Monsma, Frederick J., Jr. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :581-588

[9] Ligand docking and structure-based virtual screening in drug discovery [J].

Cavasotto, Claudio N. ;

Orry, Andrew J. W. .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) :1006-1014

[10] Protein flexibility in ligand docking and virtual screening to protein kinases [J].

Cavasotto, CN ;

Abagyan, RA .

JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (01) :209-225

← 1 2 3 4 5 6 7 8 →